| Titolo |
Pubblicato in |
Anno |
| Treating psoriatic arthritis in the early phase: proposal for a shared dermatological and rheumatological therapeutic intervention with biologics and targets synthetic disease-modifying immunosuppressive drugs |
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY |
2025 |
| Clinical and ultrasonographic remission in bio-naïve and bio-failure patients with rheumatoid arthritis at 24 weeks of upadacitinib treatment: the UPARAREMUS real-life study |
RHEUMATOLOGY AND THERAPY |
2024 |
| A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents |
MICROORGANISMS |
2024 |
| Diagnosing psoriatic arthritis in the early phase: what factors should dermatologists consider for an appropriate referral of patients with psoriasis to rheumatologists |
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY |
2024 |
| The Third Dose of BNT162b2 COVID-19 Vaccine
Does Not “Boost” Disease Flares and Adverse Events in Patients
with Rheumatoid Arthritis |
BIOMEDICINES |
2023 |
| Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine |
VACCINES |
2023 |
| Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies |
REUMATISMO |
2023 |
| Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission |
AUTOIMMUNITY REVIEWS |
2023 |
| Safety of multiple vaccinations and durability of vaccine‐induced antibodies in an Italian military cohort 5 years after immunization |
BIOMEDICINES |
2022 |
| Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
2022 |
| Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis |
FRONTIERS IN IMMUNOLOGY |
2022 |
| Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: a prospective multicenter longitudinal study |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
2022 |
| Editorial:
Chronic autoimmune arthritis, infections and vaccines |
FRONTIERS IN IMMUNOLOGY |
2022 |
| Secukinumab Treatment in Patients with Spondyloarthritis
and Concomitant Demyelinating Disease: Rationale of
IL-17 Inhibition and Clinical Outcome. |
ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS |
2022 |
| Immunogenicity of viral vaccines in the italian military |
BIOMEDICINES |
2021 |
| Inhibition of phosphodiesterase-4 in psoriatic arthritis and inflammatory bowel diseases |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2021 |
| Vitamin d signaling in gastro-rheumatology. From immuno-modulation to potential clinical applications |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2021 |
| May bacterial infections trigger bullous pemphigoid? Case report and review of literature |
MICROORGANISMS |
2021 |
| Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice |
ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ |
2021 |
| Immunosuppressive Therapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients |
FRONTIERS IN IMMUNOLOGY |
2021 |
